Stock Events

Stock Events

SciSparc 

$5.49
82
+$0.51+10.24% Wednesday 20:00
-$0.18-3.28%Wednesday 23:58After hours

Statistics

Day High
5.41
Day Low
5.35
52W High
80.1
52W Low
2.98
Volume
1,084
Avg. Volume
-
Mkt Cap
2.94M
P/E Ratio
0.05
Dividend Yield
-
Dividend
-

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-17.91
-11.94
-5.97
0
Expected EPS
0
Actual EPS
-0.7

Financials

-572.13%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
2.61MRevenue
-14.94MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SPRC. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap171.38M
Corbus Pharmaceuticals works on cannabinoid drug development, targeting similar therapeutic areas as SciSparc, making them direct competitors.
Aurora Cannabis
ACB
Mkt Cap175.92M
Aurora Cannabis is a major player in the cannabis industry, whose medical cannabis products could compete with SciSparc's cannabinoid-based therapeutics.
Canopy Growth
CGC
Mkt Cap448.42M
Canopy Growth Corporation operates in the cannabis and cannabinoid-derived product market, posing competition to SciSparc's product offerings.
Tilray Brands
TLRY
Mkt Cap570.37M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially competing with SciSparc in multiple markets.
Curaleaf
CURLF
Mkt Cap2.76B
Curaleaf Holdings is a leading U.S. provider of consumer products in cannabis, with a broad product portfolio that could compete with SciSparc's therapeutic offerings.

About

SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated with Alzheimer's disease; SCI-160, designed to address pain; and SCI-210, targeting autism spectrum disorder and epilepsy. The company has formed strategic alliances to further its goals. A partnership with Procaps focuses on the development and eventual commercial manufacturing of SCI-110, as well as CannAmide, an oral palmitoylethanolamide in a soft gel capsule. SciSparc is also collaborating with the Sheba Fund for Health Services and Research to explore SCI-210's potential in managing status epilepticus. Additionally, it has teamed up with The Israeli Medical Center for Alzheimer's to conduct a Phase IIa clinical trial, evaluating the safety, tolerability, and effectiveness of SCI-110 for patients experiencing Alzheimer's disease and agitation. Founded in 2004, the company initially operated under the name Therapix Biosciences Ltd. before changing to SciSparc Ltd. in January 2021. Its main corporate office is located in Tel Aviv-Yafo, Israel.
Show more...
CEO
Mr. Amitai Weiss
Employees
2
Country
Israel
ISIN
IL0010951403

Listings

XNAS
US
SPRC
BOATS
BOATS
SPRC.BOATS

0 Comments

Share your thoughts

FAQ

What is SciSparc stock price today?▼
The current price of SPRC is $5.49 USD — it has increased by +10.24% in the past 24 hours. Watch SciSparc stock price performance more closely on the chart.
What is SciSparc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange SciSparc stocks are traded under the ticker SPRC.
Is SciSparc stock price growing?▼
SPRC stock has risen by +14.85% compared to the previous week, the month change is a -41.03% fall, over the last year SciSparc has showed a -91.34% decrease.
What is SciSparc market cap?▼
Today SciSparc has the market capitalization of 2.94M
What were SciSparc earnings last quarter?▼
SPRC earnings for the last quarter are -0.7 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SciSparc revenue for the last year?▼
SciSparc revenue for the last year amounts to 2.61M USD.
What is SciSparc net income for the last year?▼
SPRC net income for the last year is -14.94M USD.
How many employees does SciSparc have?▼
As of July 09, 2026, the company has 2 employees.
In which sector is SciSparc located?▼
SciSparc operates in the Health & Wellness sector.
When did SciSparc complete a stock split?▼
The last stock split for SciSparc was on March 04, 2026 with a ratio of 1:9.
Where is SciSparc headquartered?▼
SciSparc is headquartered in Tel Aviv-Yafo, Israel.